Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
Corrigan KL, Xu T, Sasaki Y, Lin R, Chen AB, Welsh JW, Lin SH, Chang JY, Ning MS, Gandhi S, O'Reilly MS, Gay CM, Altan M, Lu C, Cascone T, Koutroumpakis E, Sheshadri A, Zhang X, Liao L, Zhu XR, Heymach JV, Nguyen QN, Liao Z.
Corrigan KL, et al. Among authors: xu t.
Radiother Oncol. 2024 Apr;193:110121. doi: 10.1016/j.radonc.2024.110121. Epub 2024 Feb 3.
Radiother Oncol. 2024.
PMID: 38311031